Cargando…

Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study

[Image: see text] In this study, Wedelolactone’s multitarget activity against Alzheimer’s disease was examined using density functional theory and molecular docking techniques. At physiological pH, the pK(a) and molar fractions have been estimated. The most likely relative rate constants of two radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Dang Xuan, Khang, Nguyen Huu Duy, Tri, Nguyen Huu, Nam, Pham Cam, Thong, Nguyen Minh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157682/
https://www.ncbi.nlm.nih.gov/pubmed/37151498
http://dx.doi.org/10.1021/acsomega.2c08014
_version_ 1785036806429868032
author Du, Dang Xuan
Khang, Nguyen Huu Duy
Tri, Nguyen Huu
Nam, Pham Cam
Thong, Nguyen Minh
author_facet Du, Dang Xuan
Khang, Nguyen Huu Duy
Tri, Nguyen Huu
Nam, Pham Cam
Thong, Nguyen Minh
author_sort Du, Dang Xuan
collection PubMed
description [Image: see text] In this study, Wedelolactone’s multitarget activity against Alzheimer’s disease was examined using density functional theory and molecular docking techniques. At physiological pH, the pK(a) and molar fractions have been estimated. The most likely relative rate constants of two radical scavenger mechanisms are formal hydrogen transfer in a lipid environment and single-electron transfer in a water solvent. Compared to Trolox (k(overall) = 8.96 × 10(4) M(–1) s(–1)), Wedelolactone (k(overall) = 4.26 × 10(9) M(–1) s(–1)) is more efficient in scavenging the HOO(•) radical in an aqueous environment. The chelation capacity of metals was investigated by examining the complexation of the Cu(II) ion at various coordination positions and calculating the complexation kinetic constants. Furthermore, molecular docking simulations showed that the known forms of Wedelolactone at physiological pH effectively inhibited the AChE and BChE enzymes by comparing their activity to that of tacrine (control). Wedelolactone is a promising drug candidate for Alzheimer’s disease therapy in light of these findings.
format Online
Article
Text
id pubmed-10157682
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101576822023-05-05 Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study Du, Dang Xuan Khang, Nguyen Huu Duy Tri, Nguyen Huu Nam, Pham Cam Thong, Nguyen Minh ACS Omega [Image: see text] In this study, Wedelolactone’s multitarget activity against Alzheimer’s disease was examined using density functional theory and molecular docking techniques. At physiological pH, the pK(a) and molar fractions have been estimated. The most likely relative rate constants of two radical scavenger mechanisms are formal hydrogen transfer in a lipid environment and single-electron transfer in a water solvent. Compared to Trolox (k(overall) = 8.96 × 10(4) M(–1) s(–1)), Wedelolactone (k(overall) = 4.26 × 10(9) M(–1) s(–1)) is more efficient in scavenging the HOO(•) radical in an aqueous environment. The chelation capacity of metals was investigated by examining the complexation of the Cu(II) ion at various coordination positions and calculating the complexation kinetic constants. Furthermore, molecular docking simulations showed that the known forms of Wedelolactone at physiological pH effectively inhibited the AChE and BChE enzymes by comparing their activity to that of tacrine (control). Wedelolactone is a promising drug candidate for Alzheimer’s disease therapy in light of these findings. American Chemical Society 2023-04-18 /pmc/articles/PMC10157682/ /pubmed/37151498 http://dx.doi.org/10.1021/acsomega.2c08014 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Du, Dang Xuan
Khang, Nguyen Huu Duy
Tri, Nguyen Huu
Nam, Pham Cam
Thong, Nguyen Minh
Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title_full Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title_fullStr Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title_full_unstemmed Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title_short Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
title_sort exploring the multitarget activity of wedelolactone against alzheimer’s disease: insights from in silico study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157682/
https://www.ncbi.nlm.nih.gov/pubmed/37151498
http://dx.doi.org/10.1021/acsomega.2c08014
work_keys_str_mv AT dudangxuan exploringthemultitargetactivityofwedelolactoneagainstalzheimersdiseaseinsightsfrominsilicostudy
AT khangnguyenhuuduy exploringthemultitargetactivityofwedelolactoneagainstalzheimersdiseaseinsightsfrominsilicostudy
AT tringuyenhuu exploringthemultitargetactivityofwedelolactoneagainstalzheimersdiseaseinsightsfrominsilicostudy
AT namphamcam exploringthemultitargetactivityofwedelolactoneagainstalzheimersdiseaseinsightsfrominsilicostudy
AT thongnguyenminh exploringthemultitargetactivityofwedelolactoneagainstalzheimersdiseaseinsightsfrominsilicostudy